Concussion Testing: A Novel Non-invasive Concussion Detection Device

Jan Medical, Inc.84 enrolled

Overview

The purpose of this study is to establish and evaluate a distinctive signal for concussion.

The purpose of this study is to establish a non-invasive objective measurement for the detection of concussions with the Jan Medical Device (JMD). The study will assess the ability of this device to demonstrate unique signals that correlate with concussions. The study will also test the athletes at baseline at rest and during exertion to determine if there is a difference in the signal from exertion alone. The JMD is a non-invasive band that is placed around the participants head. The JMD detects a unique pattern of signals based on displacement of the skull from changes in blood flow during individual heartbeats. The athletes will be tested longitudinally to assess to changes over time, in addition to changes after impact

Study Type

OBSERVATIONAL

Enrollment

Conditions

Concussion

Interventions

Nautilus NeuroWaveTM SystemDEVICE

Recording of subjects with Nautilus NeuroWave diagnostic device

SCATBEHAVIORAL

A Neurocognitive evaluation of the patients to assess for concussion.

Eligibility

Sex: MALEMin age: 14 YearsMax age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Junior Varsity and Varsity Players a local High School. Exclusion Criteria: * None

Locations (1)

Los Altos High School

Los Altos, California, United States

Outcomes

Primary Outcomes

A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data

Sensitivity (also called the true positive rate) measures the proportion of concussed participants that are correctly identified as such by utilizing the information within the Nautilus Neurowave data. Specificity (also called the true negative rate) measures the proportion of non-concussed participants that are correctly identified as such by utilizing the information within the Nautilus Neurowave data The information that is evaluated from within this data is recognized through the computation of two parameters, R1 and R2. Both R1 and R2 are measured by computing the frequency spectrum using an FFT of the Neurowave data and computing a ratio of the signal intensities at specific higher frequencies against specific lower frequencies within that spectrum. Based on this computation, the recorded data is evaluated as coming from a concussed participant if R1 \>= 1.0 and R2 \>= 0.66 and is considered non-concussed otherwise.

Time frame: Individual assessments were made within 2 days of recording

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.